Tuesday, March 17, 2026

Samsung Biologics Earns EcoVadis Platinum: What Joining the Top 1% Signals for Global Pharma Supply Chains

Samsung Biologics achieves Platinum rating from EcoVadis, recognizing its top-tier ESG performance in sustainability and corporate responsibility.

The $13.75 Billion Scam: Microsoft Is Accused of Blocking Competition To Keep AI Prices Sky-High

Microsoft faces a class-action lawsuit over alleged inflated ChatGPT fees due to an exclusive cloud contract with OpenAI.

U.S.-South Korea Joint Military Exercises: Why This Year’s Freedom Shield Is Different

The Freedom Shield exercise reflects a low-profile approach amid U.S. asset redeployments and North Korea's restrained responses.

Tag: regulatory standards

Bio-Revolution: Celltrion’s $700M Biosimilar Is Reshaping the Global Drug Market

Celltrion's breakthrough in antibody biosimilars is transforming healthcare, enhancing access and innovation in treatment options.

Top News

- Our Sponsors Ad -

Follow us